Mpox

Mpox is an exotic infectious disease caused by the Mpox virus. The disease was first identified in laboratory monkeys, thus earning its name, but in its natural state, it seems to infect rodents more than primates. A fever, headache, muscle pains, swollen lymph nodes, and fatigue are the first symptoms in humans. After this, a rash forms with blisters and crusts. Symptoms typically appear 7 to 14 days after exposure. In most cases, symptoms last 2 to 4 weeks. Children, pregnant women, and people with suppressed immune systems are at greater risk of severe cases.

Human Monkeypox – Epidemiology, Clinical Characteristics, Diagnosis, and Prevention

The human monkeypox virus, which belongs to the genus Orthopoxvirus of the family Poxviridae, is a DNA virus.

What is Monkeypox?

Monkeypox Epidemiology

Monkeypox 2003 U.S. Outbreak

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

Priority pathogens selected for wastewater surveillance during Paris 2024 Olympic and Paralympic Games

The study by researchers from the French national public health institute aimed to identify priority pathogens that could be suitable for wastewater surveillance (WWS) during the Paris 2024 Olympic and Paralympic Games taking place from 26 July to 11 August and 28 August to 8 September, respectively.

12 Jul 2024

New deadly strain of mpox found in DRC could spread exponentially among humans

Concerns are growing about an outbreak of deadly mpox caused by a novel, sexually transmitted strain of the virus in the southeast of the Democratic Republic of Congo (DRC).

5 Jul 2024

‘We’re flying blind’: CDC has 1M bird flu tests ready, but experts see repeat of covid missteps

It's been nearly three months since the U.S. government announced an outbreak of the bird flu virus on dairy farms.

20 Jun 2024

Rising syphilis cases highlight gaps in public knowledge on symptoms and treatment

Syphilis cases are on the rise around the globe, but many Americans don't know the symptoms.

12 Jun 2024

WHO and FIND join forces to accelerate diagnostic innovation and access

FIND and the World Health Organization (WHO) have signed a new Memorandum of Understanding (MoU) that lays the foundation for accelerating innovation and achieving equitable access to quality diagnostics for people globally.

8 Jun 2024

New study highlights ongoing mpox cases among gay and bisexual men in the U.S.

While mpox cases have sharply declined since the 2022 global outbreak, they continue to occur in the U.S. among gay and bisexual men who have sex with men (GBMSM), according to a UCLA-led study from EMERGEncy ID NET, a multisite surveillance network funded by the Centers for Disease Control and Prevention (CDC).

6 Jun 2024

Perspective delves into the rising threat of the MPX virus

Scientist at NIAID reviews the escalating global prevalence of the MPX virus, detailing its biology and transmission modes, and the urgent need for comprehensive research to understand and control its spread effectively.

13 May 2024

Lessons learned: Strategies for future pandemic response based on mpox experience

Targeted support for marginalized communities, strong public messaging and a properly coordinated Government approach led by Ministers are amongst the recommendations contained in a new evidence-based article examining how the UK should respond to future pandemics.

6 May 2024

Improving public health communication in African epidemics: Lessons learned and future directions

During epidemics of Ebola, COVID-19, Zika and other public health emergencies, effective communication of public health messages is crucial to control the spread of disease, maintain public trust, and encourage compliance with health measures.

25 Apr 2024

Mass General Hospital develops clinical decision support tool for mpox diagnosis

Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there's limited clinical experience.

5 Apr 2024

Research suggests booster doses may be necessary for monkeypox immunity

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that even in men who receives two doses of mpox vaccine intradermally, their level of antibodies to the virus falls to low or zero within the first few months if they have not received a previous smallpox vaccine.

1 Apr 2024

Study reveals waning antibody response to monkeypox vaccine over time

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination – but in people with pre-existing immunity due to childhood smallpox vaccination in childhood, antibody levels remain high in almost all cases.

1 Apr 2024

Case study: Monkeypox breakthrough infection in fully vaccinated individual

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, Spain (27-30 April) details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a 'breakthrough' mpox infection in January 2024.

1 Apr 2024

CRISPR could be used for faster monkeypox testing

Mpox, formerly known as monkeypox, is a rare viral disease that is spread through physical contact between people.

12 Feb 2024

Unraveling the architecture of poxvirus cores

A recent re-emergence and outbreak of Mpox brought poxviruses back as a public health threat, underlining an important knowledge gap at their core.

6 Feb 2024

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

The UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

24 Jan 2024

Combined vaccination and behavior change efforts averted 64% of US mpox cases, study reveals

The effectiveness of the combination of current preventive responses against monkeypox (Mpox).

10 Jan 2024

Global study reveals varied intention to receive monkeypox vaccine: 61% prevalence worldwide

The global prevalence and regional differences in the intention to receive the monkeypox.

4 Jan 2024

Smaller mpox vaccine doses and intradermal delivery elicit detectable immune response, study shows

Delivering the two-dose mpox vaccine, called JYNNEOS, in smaller than the usual FDA-approved doses, and by injection between layers of the skin rather than by the standard route under the skin, produced a detectable immune response, a new study shows.

13 Dec 2023

Pediatric viral threats surge in the 21st century: A call for One Health approach

Scoping review in "Pediatric Research" examines the rise of pediatric viral diseases in the 21st century and underscores the importance of a One Health approach, integrating human, animal, and ecosystem health, to combat these emerging and re-emerging infectious threats effectively.

9 Nov 2023

Mpox

Overview

What is Monkeypox?

Monkeypox Epidemiology

Monkeypox 2003 U.S. Outbreak

Feature Articles

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

Priority pathogens selected for wastewater surveillance during Paris 2024 Olympic and Paralympic Games

New deadly strain of mpox found in DRC could spread exponentially among humans

‘We’re flying blind’: CDC has 1M bird flu tests ready, but experts see repeat of covid missteps

Rising syphilis cases highlight gaps in public knowledge on symptoms and treatment

WHO and FIND join forces to accelerate diagnostic innovation and access

New study highlights ongoing mpox cases among gay and bisexual men in the U.S.

Perspective delves into the rising threat of the MPX virus

Lessons learned: Strategies for future pandemic response based on mpox experience

Improving public health communication in African epidemics: Lessons learned and future directions

Mass General Hospital develops clinical decision support tool for mpox diagnosis

Research suggests booster doses may be necessary for monkeypox immunity

Study reveals waning antibody response to monkeypox vaccine over time

Case study: Monkeypox breakthrough infection in fully vaccinated individual

CRISPR could be used for faster monkeypox testing

Unraveling the architecture of poxvirus cores

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

Combined vaccination and behavior change efforts averted 64% of US mpox cases, study reveals

Global study reveals varied intention to receive monkeypox vaccine: 61% prevalence worldwide

Smaller mpox vaccine doses and intradermal delivery elicit detectable immune response, study shows

Pediatric viral threats surge in the 21st century: A call for One Health approach

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Mpox

Overview

Feature Articles

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Newsletters you may be interested in